Citations (20)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Bing Liu, Meiyue Song, Huadong Qin, Bin Zhang, Yao Liu, Yu Sun, Yanfei Ma & Tiefeng Shi. (2020) Phosphoribosyl Pyrophosphate Amidotransferase Promotes the Progression of Thyroid Cancer via Regulating Pyruvate Kinase M2. OncoTargets and Therapy 13, pages 7629-7639.
Read now
Read now
Claudia Maria Hattinger, Maria Pia Patrizio, Federica Magagnoli, Silvia Luppi & Massimo Serra. (2019) An update on emerging drugs in osteosarcoma: towards tailored
therapies?. Expert Opinion on Emerging Drugs 24:3, pages 153-171.
Read now
Read now
Lu Ding, Rong Li, Rongxin Sun, Yang Zhou, Yubo Zhou, Xiaoping Han, Yong Cui, Wu Wang, Qing Lv & Jingping Bai. (2017) S-phase kinase-associated protein 2 promotes cell growth and motility in osteosarcoma cells. Cell Cycle 16:16, pages 1547-1555.
Read now
Read now
Articles from other publishers (17)
Inga Urlić, Marijana Šimić Jovičić, Karla Ostojić & Alan Ivković. (2023) Cellular and Genetic Background of Osteosarcoma. Current Issues in Molecular Biology 45:5, pages 4344-4358.
Crossref
Crossref
Shrestha Dutta, Swatilekha Ghosh, Abhishek Mishra & Rajgourab Ghosh. (2022) Oncoproteomics: insight into current proteomic technologies in cancer biomarker discovery and treatment. Journal of Proteins and Proteomics.
Crossref
Crossref
Nutnicha Sirikaew, Dumnoensun Pruksakorn, Parunya Chaiyawat & Somchai Chutipongtanate. (2022) Mass Spectrometric-Based Proteomics for Biomarker Discovery in Osteosarcoma: Current Status and Future Direction. International Journal of Molecular Sciences 23:17, pages 9741.
Crossref
Crossref
Shigao Cheng & Wanchun Wang. (2022) Analysis of the subcellular location of FAM230B and its interaction with premature miR-302b in osteosarcoma. Journal of Bone and Mineral Metabolism 40:4, pages 554-560.
Crossref
Crossref
Jihui Zhou, Li Xu, Peng Yang, Shibang Lin & Haizhou Huang. (2021) Circ-ATAD1 is overexpressed in osteosarcoma (OS) and suppresses the maturation of miR-154-5p to increase cell invasion and migration. Journal of Orthopaedic Surgery and Research 16:1.
Crossref
Crossref
Nut Koonrungsesomboon, Nuttapong Ngamphaiboon, Natavudh Townamchai, Pimpisa Teeyakasem, Chaiyut Charoentum, Pimlak Charoenkwan, Rungrote Natesirinilkul, Lalita Sathitsamitphong, Touch Ativitavas, Parunya Chaiyawat, Jeerawan Klangjorhor, Suradej Hongeng & Dumnoensun Pruksakorn. (2020) Phase II, multi-center, open-label, single-arm clinical trial evaluating the efficacy and safety of Mycophenolate Mofetil in patients with high-grade locally advanced or metastatic osteosarcoma (ESMMO): rationale and design of the ESMMO trial. BMC Cancer 20:1.
Crossref
Crossref
Peng Lin, Li‐yan Liang, Yao‐zhong Dong, Zhi‐peng Ren, He‐jun Zhao & Gui‐shi Li. (2020) Identification of Abnormal Spindle Microtubule Assembly as a Promising Therapeutic Target for Osteosarcoma. Orthopaedic Surgery 12:6, pages 1963-1970.
Crossref
Crossref
Parunya Chaiyawat, Nutnicha Sirikaew, Piyaporn Budprom, Jeerawan Klangjorhor, Areerak Phanphaisarn, Pimpisa Teeyakasem, Jongkolnee Settakorn & Dumnoensun Pruksakorn. (2020) Expression profiling of DNA methyl transferase I (DNMT1) and efficacy of a DNA-hypomethylating agent (decitabine) in combination with chemotherapy in osteosarcoma. Journal of Bone Oncology 25, pages 100321.
Crossref
Crossref
Zhe-Xiang Wang, Shao-Chun Ren, Zi-Song Chang & Jing Ren. (2020) Identification of Kinesin Family Member 2A (KIF2A) as a Promising Therapeutic Target for Osteosarcoma. BioMed Research International 2020, pages 1-9.
Crossref
Crossref
Anna M. Czarnecka, Kamil Synoradzki, Wiktoria Firlej, Ewa Bartnik, Pawel Sobczuk, Michal Fiedorowicz, Pawel Grieb & Piotr Rutkowski. (2020) Molecular Biology of Osteosarcoma. Cancers 12:8, pages 2130.
Crossref
Crossref
Jeerawan Klangjorhor, Parunya Chaiyawat, Pimpisa Teeyakasem, Nutnicha Sirikaew, Areerak Phanphaisarn, Jongkolnee Settakorn, Kriengsak Lirdprapamongkol, Sarawoot Yama, Jisnuson Svasti & Dumnoensun Pruksakorn. (2019) Mycophenolic acid is a drug with the potential to be repurposed for suppressing tumor growth and metastasis in osteosarcoma treatment. International Journal of Cancer 146:12, pages 3397-3409.
Crossref
Crossref
Sean M. Barber, Sanjay KonakondlaJonathan NakhlaJared S. FridleyJimmy Xia, Adetokunbo A. OyeleseAlbert E. TelfeianZiya L. Gokaslan. (2020) Spinal dural resection for oncological purposes: a systematic analysis of risks and outcomes in patients with malignant spinal tumors. Journal of Neurosurgery: Spine 32:1, pages 69-78.
Crossref
Crossref
Lei Cui, Jing-Yuan Zhang, Zhi-Peng Ren, He-Jun Zhao & Gui-Shi Li. (2019) APLNR promotes the progression of osteosarcoma by stimulating cell proliferation and invasion. Anti-Cancer Drugs 30:9, pages 940-947.
Crossref
Crossref
Lijun Cheng, Pankita H. Pandya, Enze Liu, Pooja Chandra, Limei Wang, Mary E. Murray, Jacquelyn Carter, Michael Ferguson, Mohammad Reza Saadatzadeh, Khadijeh Bijangi-Visheshsaraei, Mark Marshall, Lang Li, Karen E. Pollok & Jamie L. Renbarger. (2019) Integration of genomic copy number variations and chemotherapy-response biomarkers in pediatric sarcoma. BMC Medical Genomics 12:S1.
Crossref
Crossref
Yuanliang Yan, Weiping Su, Shuangshuang Zeng, Long Qian, Xi Chen, Jie Wei, Na Chen, Zhicheng Gong & Zhijie Xu. (2018) Effect and Mechanism of Tanshinone I on the Radiosensitivity of Lung Cancer Cells. Molecular Pharmaceutics 15:11, pages 4843-4853.
Crossref
Crossref
Parunya Chaiyawat, Jeerawan Klangjorhor, Jongkolnee Settakorn, Voraratt Champattanachai, Areerak Phanphaisarn, Pimpisa Teeyakasem, Jisnuson Svasti & Dumnoensun Pruksakorn. (2017) Activation Status of Receptor Tyrosine Kinases as an Early Predictive Marker of Response to Chemotherapy in Osteosarcoma. Translational Oncology 10:5, pages 846-853.
Crossref
Crossref
Wenhui Ge, Jing Li, Wenhao Fan, Delong Xu & Shangfei Sun. (2017) Tim-3 as a diagnostic and prognostic biomarker of osteosarcoma. Tumor Biology 39:7, pages 101042831771564.
Crossref
Crossref